6WL9
Cryo-em of form 2 like peptide filament, form2a
PDB DOI: 10.2210/pdb6wl9/pdb
Classification: PROTEIN FIBRIL Organism(s): N.A.
Deposited: 2020-04-18 Deposition Author(s): Beltran, L.C. , Conticello, V.P. , Egelman, E.H. , Gnewou, O.M. , Wang, F.
Experimental Data Snapshot
Method: ELECTRON MICROSCOPY Resolution: 4.2 Å
Cryo-em of form 2 like peptide filament, form2a
Beltran, L.C. , Conticello, V.P. , Egelman, E.H. , Gnewou, O.M. , Wang, F.
Primary Citation of Related Structures: 6WL9
| Proteins | ||||
|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Sequence |
| peptide Form2a | A | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 0 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | B | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 1 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | C | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 2 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | D | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 3 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | E | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 4 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | F | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 5 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | G | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 6 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | H | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 7 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | I | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 8 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | J | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | 9 | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | K | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | AA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | L | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | BA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | M | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | CA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | N | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | DA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | O | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | EA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | P | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | FA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | Q | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | GA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | R | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | HA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | S | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | IA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | T | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | JA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | U | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | KA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | V | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | LA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | W | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | MA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | X | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | NA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | Y | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | OA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | Z | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | PA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | QA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | RA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | SA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | TA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | UA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | VA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | WA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | XA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | YA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
| peptide Form2a | ZA | 29 | N.A. | QAEILKADAEILKAYAKILEAHAEILKAQ |
Experimental Data
Method: ELECTRON MICROSCOPY
Deposited Date: 2020-04-18 Deposition Author(s): Beltran, L.C. , Conticello, V.P. , Egelman, E.H. , Gnewou, O.M. , Wang, F.